Narrow search
Showing 1 - 10 of 650
Cover Image
Intellectual Property Rights and Innovation : Evidence from the Human Genome
Williams, Heidi L. - 2014
Do intellectual property (IP) rights on existing technologies hinder subsequent innovation? Using newly-collected data on the sequencing of the human genome by the public Human Genome Project and the private firm Celera, this paper estimates the impact of Celera's gene-level IP on subsequent...
Persistent link: https://www.econbiz.de/10013069502
Cover Image
The Value of Pharmacogenomic Information
Graves, John - 2017
Pharmacogenomics, or the application of genetic testing to guide drug selection and/or dosing, is often cited as integral to the vision of how precision medicine can be integrated into routine clinical practice. Yet despite a growing base of scientific discovery on genetic variation that...
Persistent link: https://www.econbiz.de/10012941158
Cover Image
The Future of Drug Development : The Economics of Pharmacogenomics
Vernon, John A.; Hughen, W. Keener; Vernon, John A. - 2021
This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...
Persistent link: https://www.econbiz.de/10013311658
Cover Image
Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment : Evidence from a Randomized Controlled Trial
Cohen, Jessica - 2012
Both under- and over-treatment of communicable diseases are public bads. But efforts to decrease one run the risk of increasing the other. Using rich experimental data on household treatment-seeking behavior in Kenya, we study the implications of this tradeoff for subsidizing life-saving...
Persistent link: https://www.econbiz.de/10013108271
Cover Image
Regulation of Private Health Insurance Markets : Lessons from Enrollment, Plan Type Choice, and Adverse Selection in Medicare Part D
Heiss, Florian - 2010
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non …-mandatory health insurance markets that control adverse selection and assure adequate access and coverage. We model Part D enrollment …
Persistent link: https://www.econbiz.de/10013150739
Cover Image
Benefits and Costs of Newer Drugs : An Update
Lichtenberg, Frank R. - 2021
Medicare enrollees with private Rx insurance is about 9% lower than the mean age of drugs used by Medicare enrollees without … either private or public Rx insurance …
Persistent link: https://www.econbiz.de/10013249231
Cover Image
Human Resource Policies and Union-Nonunion Productivity Differences
Allen, Steven G. - 2022
Many researchers in both economics departments and business schools recently have become interested in examining how much of an effect human resource decisions and policies have on firm performance. This paper surveys the literature on unionism and productivity and discusses its implications for...
Persistent link: https://www.econbiz.de/10014039024
Cover Image
How Agricultural Biotechnology Boosts Food Supply and Accomodates Biofuels
Sexton, Steven - 2015
Increased global demand for biofuels is placing increased pressure on agricultural systems at a time when traditional sources of yield improvements have been mostly exhausted, generating concerns about the future of food prices. This paper estimates the impact of global adoption of genetically...
Persistent link: https://www.econbiz.de/10013038332
Cover Image
Genetic Adverse Selection : Evidence from Long-Term Care Insurance and Huntington Disease
Oster, Emily F. - 2009
selection over time, particularly in individual-payer insurance markets; this selection could impact the viability of these … effects on morbidity, to estimate adverse selection in long-term care insurance. We find strong evidence of adverse selection … insurance. We use these estimates to make predictions about the future of this market as genetic information increases. We argue …
Persistent link: https://www.econbiz.de/10013156533
Cover Image
Damages and Injunctions in the Protection of Proprietary Research Tools
Schankerman, Mark A.; Scotchmer, Suzanne - 2021
Profit on proprietary research tools is determined partly by the remedies for infringement, such as damages and injunctions. We investigate how damages under a liability rule and the opportunity for injunctions under a property rule can affect the incentives to develop research tools. We show...
Persistent link: https://www.econbiz.de/10013228234